Hillerod Hospital

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 1 diabetes1 trial
• Ulcerative colitis1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Gentofte Hospital1 trial
• InDex Pharmaceuticals1 trial

Running trials

• Active, not recruiting

  Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controlled, investigator-initiated trial

  2022-502038-23-00· Phase 2· Gentofte Hospital· Source

Closed trials

• Terminated

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· Phase 3· InDex Pharmaceuticals· Source